If senior leaders are routinely experiencing moral distress, it can erode retention, compromise governance and decision quality, and ultimately degrade patient care—making systemic responses to institutional constraints a priority.
At Summit 2026, Mind CEO Sarah and Knuffel Trust chief executive Thea Stein led a session distinguishing moral distress from moral injury and exploring its prevalence among health and care leaders. Stein described a small qualitative study of 15 anonymous CEOs about difficult decision‑making, using the classic definition of moral distress—knowing the right action but being constrained by institutions. Speakers linked moral distress to workforce strain, structural change, political pressures to cut bureaucracy, and unrealistic expectations about quick fixes (including AI). They argued these pressures contribute to high executive turnover and impaired leadership decision‑making across the sector.
Comments
Want to join the conversation?
Loading comments...